Try our beta test site
1056 studies found for:    Open Studies | "Arthritis"
Show Display Options
Rank Status Study
21 Not yet recruiting Study of Application of Power Doppler Ultrasonography (PDUS) to Measure Response to Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)
Condition: Arthritis, Psoriatic
Interventions: Drug: AIN457 (secukinumab);   Drug: Placebo
22 Recruiting A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K
Condition: Arthritis, Rheumatoid
Intervention: Drug: ASP015K
23 Recruiting Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept;   Drug: Infliximab;   Drug: Adalimumab;   Drug: Placebo
24 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
25 Recruiting Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab
Condition: Rheumatoid Arthritis
Intervention:
26 Recruiting Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: hUC-MSC + DMARDs;   Drug: DMARDs
27 Recruiting Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan
Condition: Rheumatoid Arthritis
Intervention:
28 Not yet recruiting Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
Condition: Rheumatoid Arthritis (RA)
Intervention: Drug: Acthar
29 Recruiting Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)
Condition: Rheumatoid Arthritis
Intervention: Drug: Rituximab
30 Not yet recruiting Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Raloxifene hydrochloride;   Drug: Placebo Oral Tablet
31 Recruiting A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands
Condition: Arthritis, Psoriatic
Intervention:
32 Recruiting Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Biological: Golimumab Intravenous (IV);   Biological: Infliximab;   Biological: Biosimilar Infliximab
33 Recruiting A Multicenter Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis.
Condition: Psoriatic Arthritis
Interventions: Other: Placebo;   Drug: Bimekizumab
34 Recruiting A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: ASP1707;   Drug: Placebo
35 Recruiting The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?
Conditions: Inflammatory Arthritis;   Rheumatoid Arthritis
Intervention:
36 Recruiting Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: bDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept)
37 Recruiting Kunxian for the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Kunxian Capsule;   Drug: Methotrexate
38 Recruiting Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
Condition: Rheumatoid Arthritis
Intervention:
39 Recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
40 Not yet recruiting ART-I02 in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Genetic: ART-I02

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.